Thursday, May 5, 2016

BioSante and ANI agree to merge

BioSante and ANI agree to merge

October 4, 2012 by · Leave a Comment 

Tweet BioSante Pharmaceuticals (NASDAQ:BPAX) and closely held ANI Pharmaceuticals have agreed to merge in an all-stock transaction. The merger will bring together BioSante’s cash, anticipated future licensing revenues and other assets, including products in development, with ANI’s branded and generic pharmaceutical products and contract manufacturing operations, which together generated net sales of over $16-million in […]

In conversation with Michael King and Elemer Piros

In conversation with Michael King and Elemer Piros

September 20, 2011 by · Leave a Comment 

Tweet Rodman & Renshaw’s 13th Annual Healthcare Conference last week was another roaring success. Held in conjunction with Rodman’s Annual Global Investment Conference, total attendees reached some 4,000, with 400 presenting companies from the healthcare, mining, energy, financial services and clean technology sectors, Israel and China. In this exclusive interview with BioTuesdays.com, two of Rodman’s […]

BioSante PK study adds to LibiGel safety and efficacy confidence

BioSante PK study adds to LibiGel safety and efficacy confidence

September 13, 2011 by · Leave a Comment 

Tweet BioSante Pharmaceuticals’ (NASDAQ:BPAX) successful pharmacokinetic study of its LibiGel (testosterone gel) treatment for female sexual dysfunction, specifically hypoactive sexual desire disorder (HSDD), is adding to the company’s overall confidence that its ongoing, long-term safety study also will be favorable, as will its efficacy trials. “This pharmacokinetic study seems to corroborate our LibiGel safety study, […]

Email Newsletters with Constant Contact
Google+